Means Investment Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-13,058
| Closed | -$367K | – | 222 |
|
|
2026
Q1 | $367K | Buy |
13,058
+124
| +1% | +$3.3K | 0.03% | 147 |
|
|
2025
Q4 | $322K | Buy |
12,934
+4,346
| +51% | +$110K | 0.03% | 151 |
|
|
2025
Q3 | $219K | Sell |
8,588
-6,099
| -42% | -$151K | 0.02% | 182 |
|
|
2025
Q2 | $356K | Sell |
14,687
-22,379
| -60% | -$522K | 0.03% | 149 |
|
|
2025
Q1 | $939K | Sell |
37,066
-27,907
| -43% | -$730K | 0.1% | 88 |
|
|
2024
Q4 | $1.72M | Buy |
64,973
+1,661
| +3% | +$45.1K | 0.18% | 68 |
|
|
2024
Q3 | $1.83M | Buy |
63,312
+21,939
| +53% | +$640K | 0.2% | 65 |
|
|
2024
Q2 | $1.16M | Buy |
41,373
+11,423
| +38% | +$314K | 0.14% | 84 |
|
|
2024
Q1 | $831K | Sell |
29,950
-4,332
| -13% | -$120K | 0.11% | 97 |
|
|
2023
Q4 | $987K | Sell |
34,282
-4,785
| -12% | -$145K | 0.14% | 93 |
|
|
2023
Q3 | $1.3M | Sell |
39,067
-609
| -2% | -$21.5K | 0.21% | 78 |
|
|
2023
Q2 | $1.46M | Sell |
39,676
-3,420
| -8% | -$133K | 0.23% | 78 |
|
|
2023
Q1 | $1.76M | Sell |
43,096
-957
| -2% | -$41.3K | 0.31% | 63 |
|
|
2022
Q4 | $2.26M | Buy |
44,053
+1,307
| +3% | +$62.7K | 0.45% | 49 |
|
|
2022
Q3 | $1.87M | Sell |
42,746
-809
| -2% | -$39.3K | 0.41% | 54 |
|
|
2022
Q2 | $2.28M | Buy |
43,555
+392
| +0.9% | +$20K | 0.48% | 46 |
|
|
2022
Q1 | $2.23M | Buy |
43,163
+995
| +2% | +$51.6K | 0.4% | 52 |
|
|
2021
Q4 | $2.49M | Sell |
42,168
-43
| -0.1% | -$2.13K | 0.44% | 49 |
|
|
2021
Q3 | $1.81M | Sell |
42,211
-228
| -0.5% | -$10.1K | 0.36% | 56 |
|
|
2021
Q2 | $1.66M | Buy |
42,439
+2,637
| +7% | +$103K | 0.33% | 62 |
|
|
2021
Q1 | $1.44M | Buy |
39,802
+691
| +2% | +$24.5K | 0.33% | 62 |
|
|
2020
Q4 | $1.35M | Buy |
39,111
+1,969
| +5% | +$72.2K | 0.31% | 63 |
|
|
2020
Q3 | $1.28M | Sell |
37,142
-5,230
| -12% | -$183K | 0.35% | 55 |
|
|
2020
Q2 | $1.52M | Sell |
42,372
-319
| -0.7% | -$10.8K | 0.48% | 46 |
|
|
2020
Q1 | $1.47M | Sell |
42,691
-788
| -2% | -$26.9K | 0.57% | 47 |
|
|
2019
Q4 | $1.67M | Sell |
43,479
-456
| -1% | -$16.2K | 0.56% | 51 |
|
|
2019
Q3 | $1.58M | Sell |
43,935
-1,971
| -4% | -$71.7K | 0.6% | 51 |
|
|
2019
Q2 | $1.89M | Sell |
45,906
-2,890
| -6% | -$115K | 0.77% | 43 |
|
|
2019
Q1 | $1.97M | Buy |
48,796
+3,879
| +9% | +$155K | 0.86% | 36 |
|
|
2018
Q4 | $1.86M | Buy |
+44,917
| New | +$1.86M | 1.03% | 28 |
|
Other funds holding PFE
Means Investment Company's PFE Position: Q2 2026 in Review
Means Investment Company sold out of Pfizer (PFE) in Q2 2026, closing a stake of 13,058 shares — an estimated $367K sold.
Means Investment Company first reported a position in PFE in Q4 2018 and held it in 30 quarters. The position peaked at $2.49M in Q4 2021. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Means Investment Company reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Means Investment Company sold 13,058 Pfizer shares in Q2 2026, an estimated $367K.
- Means Investment Company first reported a position in Pfizer in Q4 2018 and held it in 30 quarters.
- Means Investment Company's Pfizer position peaked at $2.49M in Q4 2021.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Means Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.